{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T01:56:23Z","timestamp":1769565383942,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12229-y","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T09:02:19Z","timestamp":1766653339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of risk factors associated with in-hospital mortality in severe HIV-negative PCP patients: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Qi","family":"Yanmeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu","family":"Huadong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"issue":"12","key":"12229_CR1","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1080\/14656566.2021.1915989","volume":"22","author":"RB Weyant","year":"2021","unstructured":"Weyant RB, Kabbani D, Doucette K, et al. Pneumocystis jirovecii: a review with a focus on prevention and treatment. J Expert Opin Pharmacother. 2021;22(12):1579\u201392. 10 1080 14656566 2021 1915989.","journal-title":"J Expert Opin Pharmacother"},{"key":"12229_CR2","unstructured":"Yetmar ZA, Duffy D, Smith BH, et al. risk factors and outcomes of pneumocystis pneumonia in solid organ transplant recipients impact of post trans plant lymphopro life rative disorder. J Clin Transplant. 2023;37(9):e15021. https:\/\/doi.org\/10.1111-ctr-15021."},{"issue":"1","key":"12229_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1468-1293.2010.00857.x","volume":"12","author":"A Antinori","year":"2011","unstructured":"Antinori A, Coenen T, Costagiola D, et al. Late presentation of HIV infection: a consensus definition. HIV Med. 2011;12(1):61\u201364.","journal-title":"HIV Med"},{"issue":"9738","key":"12229_CR4","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/S0140-6736(10)60932-4","volume":"376","author":"RK Lodwick","year":"2010","unstructured":"Lodwick RK, Sabin CA, Porter K, et al. Death rates in HIV positive antiretroviral-naive patients with cd4 count greater than 350 cells per microl in Europe and North America: a pooled cohort observational study. Lancet. 2010;376(9738):340\u201345.","journal-title":"Lancet"},{"key":"12229_CR5","doi-asserted-by":"publisher","first-page":"862 872","DOI":"10.1093\/infdis\/jiw085","volume":"214","author":"K Buchacz","year":"2016","unstructured":"Buchacz K, Lau B, Jing Y, Bosch R, Abraham AG, Gill MJ, et al. Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV infected persons in the United States and Canada, 2000-2010. J Infect Dis. 2016;214:862 872. https:\/\/doi.org\/10.1093\/infdis\/jiw085.","journal-title":"J. Infect. Dis"},{"key":"12229_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jinf.2016.10.005","volume":"74","author":"M Pegorie","year":"2017","unstructured":"Pegorie M, Denning DW, Welfare W. Estimating the burden of invasive and serious fungal disease in the United Kingdom. J Infect. 2017;74:60\u201371. https:\/\/doi.org\/10.1016\/j.jinf.2016.10.005.","journal-title":"J. Infect"},{"key":"12229_CR7","doi-asserted-by":"publisher","unstructured":"Xue T, Kong X, Ma L. Trends in the epidemiology of pneumocystis pneumonia in immunocompromised patients without HIV infection. J. Fungi (Basel). 2023;9. https:\/\/doi.org\/10.3390\/jof9080812.","DOI":"10.3390\/jof9080812"},{"issue":"1","key":"12229_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s13054-018-2221-8","volume":"22","author":"JJ Schmidt","year":"2018","unstructured":"Schmidt JJ, Lueck C, Ziesing S, et al. Clinical course, treat ment and outcome of pneumocystis pneumonia in immuno compromised adults: a retrospective analysis over 17 years. Crit Care. 2018;22(1):307\u201315. 10.","journal-title":"Crit Care"},{"key":"12229_CR9","doi-asserted-by":"crossref","unstructured":"Kim SJ, Lee J, Cho YJ, et al. Prognostic factors of pneumocystis jirovecii pneumonia in patients without HIV infection. J Infect. 2014;69(1):88\u201395.","DOI":"10.1016\/j.jinf.2014.02.015"},{"key":"12229_CR10","doi-asserted-by":"crossref","unstructured":"Ko Y, Jeong BH, Park HY, et al. Outcomes of pneumocystis pneumonia with respiratory failure in HIV-negative patients. J Crit Care. 2014;29(3):356\u201361.","DOI":"10.1016\/j.jcrc.2013.12.005"},{"key":"12229_CR11","unstructured":"Yangang L, Feiruan Z, Qingtao Z, et al. Analysis of clinical characteristics of patients with severe pneumocystis pneumonia caused by human immunodeficiency virus-negative infection. J Int Respir J 2021. 41(15):1126\u201331. https:\/\/doi.org\/10.3760-cma-j-cn131368-20201224-01172."},{"key":"12229_CR12","doi-asserted-by":"crossref","unstructured":"KoR E, Na SJ, Huh K, et al. Association of time-to-treatment without comes of pneumocystis pneumonia with respiratory failure in HIV-negative patients. J Respir Res. 2019;20(1):213. https:\/\/doi.org\/10.1186-s12931-019-1188-6.","DOI":"10.1186\/s12931-019-1188-6"},{"key":"12229_CR13","doi-asserted-by":"publisher","unstructured":"Mori SU, Miyamura Y, T, et al. Outcomes and risk factors for mortality in pneumocystis pneumonia patients with rheumatoidarthritis a multi centre retrospective cohort study. J Mod Rheumatol. 2023;33(4):723\u201331. https:\/\/doi.org\/10.1093\/mr-roac088.","DOI":"10.1093\/mr-roac088."},{"key":"12229_CR14","doi-asserted-by":"crossref","unstructured":"Wang YH, Sun X, T, et al. Non-HIV-infected patients with Pneumocystis pneumonia in the intensive care unit a bicentric retrospective study focused on predictive factors of in-hospital mortality. J Clin Respir J. 2022;16(2):152\u201361. https:\/\/doi.org\/10.1111-crj-13463.","DOI":"10.1111\/crj.13463"},{"key":"12229_CR15","doi-asserted-by":"crossref","unstructured":"Chung CL, Oh CM, YM, et al. Prognostic implication of bronchial veolar lavage fluid analysis in patients with Pneumocystis jirovecii pneumonia without human immune deficiency virus infection. J BMCPulm Med. 2022;22(1):251. https:\/\/doi.org\/10.1186-s12890-022-02041-8.","DOI":"10.1186\/s12890-022-02041-8"},{"issue":"1","key":"12229_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12879-023-08372-z","volume":"23","author":"H Qi","year":"2023","unstructured":"Qi H, Dong D, Liu N, Xu Y, Qi M, Gu Q. Efficacy of initial caspofung in plus trimethoprim\/sulfamethoxazole for severe PCP in patients without human immunodeficiency virus infection. BMC Infect Dis. 2023, Jun, 16;23(1):409. https:\/\/doi.org\/10.1186\/s12879-023-08372-z. PMID: 37328748; PMCID: PMC10273704.","journal-title":"BMC Infect Dis"},{"key":"12229_CR17","doi-asserted-by":"publisher","unstructured":"Armstrong-James D, Stebbing J, John L, et al. A trial of caspofungin salvage treatment in PCP pneumonia. Thorax. 2011;66(6):537\u201338. https:\/\/doi.org\/10.1136\/thx.2010.135350.","DOI":"10.1136\/thx.2010.135350"},{"issue":"6","key":"12229_CR18","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group Education and research consortium. Clin Infect Dis. 2020;71(6):1367\u201376.","journal-title":"Clin Infect Dis"},{"key":"12229_CR19","doi-asserted-by":"publisher","unstructured":"The AIDS and Hepatitis Group of the Infectious Diseases Society of Chinese Medical Association. Expert consensus on diagnosis and treatment of aids complicated with pneumocystis pneumonia (2024 edition). Chin J Clin Infect Dis. 2024. 2024;17(2):81\u201392. https:\/\/doi.org\/10.3760\/cma.j.issn.1674-2397.","DOI":"10.3760\/cma.j.issn.1674-2397"},{"issue":"1","key":"12229_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4065\/71.1.5","volume":"71","author":"SH Yale","year":"1996","unstructured":"Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc. 1996;71(1):5\u201313.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"12229_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s13054-018-2221-8","volume":"22","author":"JJ Schmidt","year":"2018","unstructured":"Schmidt JJ, Lueck C, Ziesing S, et al. Clinical course, treatment and outcome of pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years. Crit Care. 2018;22(1):307\u201315.","journal-title":"Crit Care"},{"issue":"9","key":"12229_CR22","doi-asserted-by":"publisher","first-page":"e139144","DOI":"10.1371\/journal.pone.0139144","volume":"10","author":"M Chen","year":"2015","unstructured":"Chen M, Tian X, Qin F, et al. Pneumocystis pneumonia in patients with autoimmune diseases: a retrospective study focused on clinical characteristics and prognostic factors related to death. PLoS One. 2015;10(9):e139144.","journal-title":"PLoS One"},{"issue":"12","key":"12229_CR23","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.amjmed.2014.07.010","volume":"127","author":"P Fillatre","year":"2014","unstructured":"Fillatre P, Decaux O, Jouneau S, et al. Incidence of pneumocystis jiroveci pneumonia among groups at risk in HIV negative patients. Am J Med. 2014;127(12):1211\u201342.","journal-title":"Am J Med"},{"issue":"1","key":"12229_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0163-4453(03)00038-0","volume":"47","author":"F Roblot","year":"2003","unstructured":"Roblot F, Le Moal G, Godet C, et al. Pneumocystis carinii pneumonia in patients with hematologic malignancies: a descriptive study. J Infect. 2003;47(1):19\u201327.","journal-title":"J Infect"},{"issue":"6","key":"12229_CR25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/01.md.0000145370.63676.fb","volume":"83","author":"E Azoulay","year":"2004","unstructured":"Azoulay E, Thiery G, Chevret S, et al. The prognosis of acute respiratory failure in critically ill cancer patients. Med (Baltim). 2004;83(6):360\u201370.","journal-title":"Med (Baltim)"},{"issue":"6","key":"12229_CR26","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1097\/00003246-199906000-00030","volume":"27","author":"JP Bedos","year":"1999","unstructured":"Bedos JP, Dumoulin JL, Gachot B, et al. Pneumocystis carinii pneumonia requiring intensive care management: survival and prognostic study in 110 patients with human immunodefi ciency virus. Crit Care Med. 1999;27(6):1109\u201315.","journal-title":"Crit Care Med"},{"key":"12229_CR27","doi-asserted-by":"crossref","unstructured":"Kollef MH. Ventilator-associated pneumonia: the role of emerging therapies and diagnostics. Chest. 2015 1450;147(6):1448.","DOI":"10.1378\/chest.14-2745"},{"issue":"4","key":"12229_CR28","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.bjid.2014.04.004","volume":"18","author":"IP Safe","year":"2014","unstructured":"Safe IP, Oliveira VC, Marinho PM, et al. Spontaneous pneumo thorax: a fatal complication in HIV-infected patients. Braz J Infect Dis. 2014;18(4):466.","journal-title":"Braz J Infect Dis"},{"key":"12229_CR29","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.2147\/IDR.S199761","volume":"12","author":"CJ Liu","year":"2019","unstructured":"Liu CJ, Lee TF, Ruan SY, Yu CJ, Chien JY, Hsueh PR. Clinical characteristics, treatment outcomes, and prognostic factors of pneumocystis pneumonia in non-HIV-infected patients. Infect Drug Resist. 2019;12:1457\u201367.","journal-title":"Infect Drug Resist"},{"key":"12229_CR30","doi-asserted-by":"publisher","first-page":"59729","DOI":"10.18632\/oncotarget.19927","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu Y, Su L, Jiang SJ, Qu H. Risk factors for mortality from pneu mocystis carinii pneumonia (PCP) in non-HIV patients: a meta analysis. Oncotarget. 2017;8:59729\u201339.","journal-title":"Oncotarget"},{"key":"12229_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/ars.2020.8142","volume":"35","author":"F Violi","year":"2021","unstructured":"Violi F, Cangemi R, Romiti GF, Ceccarelli G, Oliva A, Alessandri F, et al. Is albumin predictor of mortality in COVID-19? Antioxid. Redox Signal. 2021;35:139\u201342. [CrossRef] [PubMed].","journal-title":"Redox Signal"},{"key":"12229_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12931-020-01427-8","volume":"21","author":"M-Y Wu","year":"2020","unstructured":"Wu M-Y, Yao L, Wang Y, Zhu X-Y, Wang X-F, Tang P-J, et al. Clinical evaluation of potential usefulness of serum lactate dehydrogenase (LDH) in 2019 novel coronavirus (COVID-19) pneumonia. Respir. Res. 2020;21:171. [CrossRef] [PubMed].","journal-title":"Respir. Res"},{"key":"12229_CR33","doi-asserted-by":"publisher","first-page":"14977","DOI":"10.1038\/s41598-018-33361-7","volume":"8","author":"TK Oh","year":"2018","unstructured":"Oh TK, Song IA, Lee JH. Clinical usefulness of C-reactive protein to albumin ratio in predicting 30-day mortality in critically ill patients: a retrospective analysis. Sci Rep. 2018;8:14977. [CrossRef].","journal-title":"Sci. Rep"},{"key":"12229_CR34","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jinf.2012.12.007","volume":"66","author":"D Viasus","year":"2013","unstructured":"Viasus D, Garcia-Vidal C, Simonetti A, Manresa F, Dorca J, Gudiol F, et al. Prognostic value of serum albumin levels in hospitalized adults with community-acquired pneumonia. J Infect. 2013;66:415\u201323. [CrossRef].","journal-title":"J. Infect"},{"key":"12229_CR35","doi-asserted-by":"publisher","first-page":"e0132109","DOI":"10.1371\/journal.pone.0132109","volume":"10","author":"MH Kim","year":"2015","unstructured":"Kim MH, Ahn JY, Song JE, Choi H, Ann HW, Kim JK, et al. The C-Reactive Protein\/Albumin ratio as an Independent predictor of mortality in patients with severe sepsis or septic shock treated with early goal-directed therapy. PLoS One. 2015;10:e0132109. [CrossRef].","journal-title":"PLoS One"},{"key":"12229_CR36","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jcrc.2010.10.007","volume":"26","author":"JH Lee","year":"2011","unstructured":"Lee JH, Kim J, Kim K, Jo YH, Rhee J, Kim TY, et al. Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia. J Crit Care. 2011;26:287\u201394. [CrossRef].","journal-title":"J. Crit. Care"},{"key":"12229_CR37","first-page":"205","volume":"12","author":"OS Dizdar","year":"2014","unstructured":"Dizdar OS, Ersoy A, Akalin H. Pneumonia after kidney transplant: incidence, risk factors, and mortality Exp Clin Transpl 2014;12:205\u201311.","journal-title":"Exp. Clin. Transpl"},{"key":"12229_CR38","doi-asserted-by":"publisher","unstructured":"Yu YT, Liu J, Hu B, et al. Expert consensus on the use of human serum albumin in critically ill patients.Chin Med J(Engl). 2021;134(14):1639\u201354. https:\/\/doi.org\/10.1097\/CM9.0000000000001661.","DOI":"10.1097\/CM9.0000000000001661"},{"key":"12229_CR39","doi-asserted-by":"publisher","unstructured":"Jingjing Z, Xuteng J, Ruohan L, et al. Correlation analysis of average serum albumin level during ICU hospitalization and patient outcomes - a multicenter retrospective cohort study. Chin J Emerg Med. 2022;42(6):476\u201380. https:\/\/doi.org\/10.3969\/j.issn.022.06.003.","DOI":"10.3969\/j.issn.022.06.003"},{"key":"12229_CR40","doi-asserted-by":"publisher","first-page":"680108","DOI":"10.3389\/fpubh.2021.680108","volume":"9","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhou X, Saimi M, et al. Risk factors of mortality from pneumocystis pneumonia in non-HIV patients: a meta-analysis. Front Public Health. 2021;9:680108.","journal-title":"Front Public Health"},{"key":"12229_CR41","doi-asserted-by":"publisher","first-page":"797 806","DOI":"10.1007\/s10654-022-00866-5","volume":"37","author":"P Geldsetzer","year":"2022","unstructured":"Geldsetzer P, Mukama T, Jawad NK, Riffe T, Rogers A, Sudharsanan N. Sex differences in the mortality rate for coronavi Rus disease 2019 compared to other causes of death: an analysis of population-wide data from 63 countries. Eur J Epidemiol. 2022;37:797 806.","journal-title":"Eur J Epidemiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12229-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12229-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12229-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:03:14Z","timestamp":1769518994000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12229-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12229"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12229-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and relevant guidelines and regulations. This study was approved by the Ethics Review Committee of Peking Union Medical College Hospital (No. K8993). Since no personal identifiable information was used in this analysis, the need for informed personal consent was waived by the Ethics Review Committee of Peking Union Medical College Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"187"}}